Study Shows Ongoing Benefits Once Immunotherapy Stops
A study from the University of Texas MD Anderson Cancer Center’s Department of Gastrointestinal Medical Oncology has found that some patients continue to benefit from immunotherapy once the treatment stops. Researchers found that some metastatic colorectal cancer patients are reluctant to stop the treatment as per their doctors’ recommendations, suggesting that discontinuing the treatment doesn’t always stop its benefits. University of Texas MD Anderson Cancer Center associate professor and senior study author Dr. Van Morris and his research team wanted to determine if the health benefits of immunotherapy continued once the treatment was discontinued or due to side effects. The…